Chapter PDF
References
Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ (2000) The registry of the international society for heart and lung transplantation: Seventeenth official report-2000. J Heart Lung Transplant 19:909–931
Veldhuizen RA, Lee J, Sandler D, et al (1993) Alterations in pulmonary surfactant composition and activity after experimental lung transplantation. Am Rev Respir Dis 148:208–215
Erasmus ME, Petersen AH, Oetomo SB, Prop J (1994) The function of surfactant is impaired during the reimplantation response in rat lung transplants. J Heart Lung Transplant 13:791–802
Erasmus ME, Petersen AH, Hofstede G, Haagsman HP, Bambang Oetomo S, Prop J (1996) Surfactant treatment before reperfusion improves the immediate function of lung transplants in rats. Am J Respir Crit Care Med 153:665–670
Novick RJ, Gilpin AA, Gehman KE, et al (1997) Mitigation of injury in canine lung grafts by exogenous surfactant therapy. J Thorac Cardiovasc Surg 113:342–353
Novick RJ, Veldhuizen RA, Possmayer F, Lee J, Sandler D, Lewis JF (1994) Exogenous surfactant therapy in thirty-eight hour lung graft preservation for transplantation. J Thorac Cardiovasc Surg 108:259–268
Khan SU, Salloum J, O'Donovan PB, et al (1999) Acute pulmonary edema after lung transplantation: The pulmonary reimplantation response. Chest 116:187–194
King RC, Binns OA, Rodriguez F, et al (2000) Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 69:1681–1685
Lee KH, Martich GD, Boujoukos AJ, Keenan RJ, Griffith BP (1996) Predicting icu length of stay following single lung transplantation. Chest 110:1014–1017
de Perrot M, Liu M, Waddell TK, Keshavjee S (2003) Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167:490–511
Lachmann B (1987) The role of pulmonary surfactant in the pathogenesis and therapy of ARDS. In: Vincent JL (ed) Update in Intensive Care and Emergency Medicine. Springer, Heidelberg, pp 123–124
Ingbar DH (2000) Mechanisms of repair and remodeling following acute lung injury. Clin Chest Med 21:589–616
Boehler A, Kesten S, Weder W, Speich R (1998) Bronchiolitis obliterans after lung transplantation: A review. Chest 114:1411–1426
Fiser SM, Tribble CG, Long SM, et al (2002) Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 73:1041–1047
Tullius SG, Tilney NL (1995) Both alloantigen-dependent and-independent factors influence chronic allograft rejection. Transplantation 59:313–318
Andrade RS, Solien EE, Wangensteen OD, Tsai MY, Kshettry VR, Bolman RM, 3rd (1995) Surfactant dysfunction in lung preservation. Transplantation 60:536–541
Klepetko W, Lohninger A, Wisser W, et al (1990) Pulmonary surfactant in bronchoalveolar lavage after canine lung transplantation: Effect of l-carnitine application. J Thorac Cardiovasc Surg 99:1048–1058
Erasmus ME, Veldhuizen RA, Novick RJ, Lewis JF, Prop J (1996) The effect of lung preservation on alveolar surfactant. Transplantation 62:143–144
Erasmus ME, Hofstede GJ, Petersen AH, et al (2002) Sp-a-enriched surfactant for treatment of rat lung transplants with sp-a deficiency after storage and reperfusion. Transplantation 73:348–352
Hohlfeld JM, Tiryaki E, Hamm R, et al (1998) Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Care Med 158:706–712
Haitsma JJ, Papadakos PJ, Lachmann B (2004) Surfactant therapy for acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 10:18–22
Griese M (1999) Pulmonary surfactant in health and human lung diseases: State of the art. Eur Respir J 13:1455–1476
Haitsma JJ, Lachmann RA, Lachmann B (2003) Lung protective ventilation in ards: Role of mediators, peep and surfactant. Monaldi Arch Chest Dis 59:108–118
Lachmann B, Eijking EP, So KL, Gomroers D (3994) In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Intensive Care Med 20:6–11
Grace PA, Mathie RT (1999) Ischaemia-reperfusion Injury. Blackwell Science Ltd, London
Buchanan SA, Mauney MC, Parekh VI, et al (1996) Intratracheal surfactant administration preserves airway compliance during lung reperfusion. Ann Thorac Surg 62:1617–1621
Erasmus ME, Hofstede GJ, Petersen AH, Haagsman HP, Oetomo SB, Prop J (1997) Effects of early surfactant treatment persisting for one week after lung transplantation in rats. Am J Respir Crit Care Med 156:567–572
Gunther A, Balser M, Schmidt R, et al (2004) Surfactant abnormalities after single lung transplantation in dogs: Impact of bronchoscopic surfactant administration. J Thorac Cardiovasc Surg 127:344–354
Struber M, Hohlfeld JM, Kofidis T, et al (2002) Surfactant function in lung transplantation after 24 hours of ischemia: Advantage of retrograde flush perfusion for preservation. J Thorac Cardiovasc Surg 123:98–103
Koletsis E, Chatzimichalis A, Fotopoulos V, et al (2003) Donor lung pretreatment with surfactant in experimental transplantation preserves graft hemodynamics and alveolar morphology. Exp Biol Med (Maywood) 228:540–545
Krishnadasan B, Naidu B, Rosengart M, et al (2002) Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus. J Thorac Cardiovasc Surg 123:756–767
Takeyoshi I, Otani Y, Koibuchi Y, et al (1999) Effects of fr167653 on pulmonary ischemia-reperfusion injury: Administration timing. Transplant Proc 31:1935–1936
Warnecke G, Sommer SP, Gohrbandt B, et al (2004) Warm or cold ischemia in animal models of lung ischemia-reperfusion injury: Is there a difference? Thorac Cardiovasc Surg 52:174–179
Oosting RS, van Greevenbroek MM, Verhoef J, van Golde LM, Haagsman HP (1991) Structural and functional changes of surfactant protein a induced by ozone. Am J Physiol 261:L77–83
Friedrich I, Borgermann J, Splittgerber FH, et al (2004) Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs. J Thorac Cardiovasc Surg 127:335–343
Warnecke G, Struber M, Fraud S, Hohlfeld JM, Haverich A (2001) Combined exogenous surfactant and inhaled nitric oxide therapy for lung ischemia-reperfusion injury in minipigs. Transplantation 71:1238–1244
Andrade RS, Wangensteen OD, Jo JK, Tsai MY, Bolman RM 3rd (2000) Effect of hypothermic pulmonary artery flushing on capillary filtration coefficient. Transplantation 70:267–271
Struber M, McGregor CG, Locke TJ, Miller VM (1990) Effect of flush-perfusion with eurocollins solution on pulmonary arterial function. Transplant Proc 22:2206–2211
Struber M, Ehlers KA, Nilsson FN, Miller VM, McGregor CG, Haverich A (1997) Effects of lung preservation with euro-collins and university of wisconsin solutions on endothelium-dependent relaxations. Ann Thorac Surg 63:1428–1435
Struber M, Hoblfeld JM, Fraund S, Kim P, Warnecke G, Haverich A (2000) Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function. J Thorac Cardiovasc Surg 120:566–572
Cockshutt AM, Weitz J, Possmayer F (1990) Pulmonary surfactant-associated protein a enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29:8424–8429
Semik M, Schnabel R, Bruske T, et al (1994) Ultrastructural studies of acute rejection following single lung transplantation in the rat-histological and immunohistological findings. Thorac Cardiovasc Surg 42:290–297
Hohlfeld JM, Struber M, Ahlf K, et al (1999) Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs. Eur Respir J 13:1037–1043
Struber M, Wilhelmi M, Harringer W, et al (2001) Flush perfusion with low potassium, dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg 19:190–194
Novick RJ, MacDonald J, Veldhuizen RA, et al (1996) Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation. Am J Respir Crit Care Med 154:98–104
Hausen B, Rohde R, Hewitt CW, et al (1997) Exogenous surfactant treatment before and after sixteen hours of ischemia in experimental lung transplantation. J Thorac Cardiovasc Surg 113:1050–1058
Casals C, Varela A, Ruano ML, et al (1998) Increase of c-reactive protein and decrease of surfactant protein a in surfactant after lung transplantation. Am J Respir Crit Care Med 157:43–49
Novick RJ, Gehman KE, Ali IS, Lee J (1996) Lung preservation: The importance of endothelial and alveolar type ii cell integrity. Ann Thorac Surg 62:302–314
Thomassen MJ, Meeker DP, Antal JM, Connors MJ, Wiedemann HP (1992) Synthetic surfactant (exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am J Respir Cell Mol Biol 7:257–260
Speer CP, Gotze B, Curstedt T, Robertson B (1991) Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (curosurf). Pediatr Res 30:69–74
Matalon S, Holm BA, Baker RR, Whitfield MK, Freeman BA (1990) Characterization of antioxidant activities of pulmonary surfactant mixtures. Biochim Biophys Acta 1035:121–127
Struber M, Hirt SW, Cremer J, Harringer W, Haverich A (1999) Surfactant replacement in reperfusion injury after clinical lung transplantation. Intensive Care Med 25:862–864
Struber M, Cremer J, Harringer W, Hirt SW, Costard-Jackle A, Haverich A (1995) Nebulized synthetic surfactant in reperfusion injury after single lung transplantation. J Thorac Cardiovasc Surg 110:563–564
Della Rocca G, Pierconti F, Costa MG, et al (2002) Severe reperfusion lung injury after double lung transplantation. Crit Care 6:240–244
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Van der Kaaij, N., Bogers, A., Lachmann, B. (2005). Ischemia-reperfusion Injury of the Lung: Role of Surfactant. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 2005. EN]Yearbook of Intensive Care and Emergency Medicine, vol 2005. Springer, New York, NY. https://doi.org/10.1007/0-387-26272-5_6
Download citation
DOI: https://doi.org/10.1007/0-387-26272-5_6
Publisher Name: Springer, New York, NY
Print ISBN: 978-3-540-23476-0
Online ISBN: 978-0-387-26272-7
eBook Packages: MedicineMedicine (R0)